← Back to headlines
Higher-Dose Wegovy Shows Significant Weight Loss in Patients
Novo Nordisk has announced that a higher-dose version of its weight-loss drug, Wegovy, helped some patients lose nearly 28% of their body weight. Early responders to the increased dosage showed additional significant weight reduction.
12 May, 11:05 — 12 May, 14:00
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual89d ago
Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity injection Wegovy.
Read full article →seeking-alphaMixed89d ago
Novo says early responders to higher-dose Wegovy lost additional body weight
Read full article →Coverage Timeline
First report: seeking-alpha · 12 May, 11:05|Full coverage: 2 · 3h|Window: 3h
Left-leaningCenterRight-leaning
Related Stories
Recipe for a Healthy Gut: 30 Different Products Per Week Work Wonders
28m ago
Sales of Suspected PFAS Pesticide Rise in Denmark Amid Contamination Fears
29m ago
Mosquitoes Consciously Choose Hosts Based on Skin Secretions and Microorganisms
38m ago
WHO Recommends Clinical Trial for Ebola Vaccine Against Bundibugyo Virus
39m ago